Healthcare and Life Science
CellCentric wins Business of the Year at 36th Business Weekly Awards ahead of tipped US IPO
Tony Quested writes: CEO Will West winged in from New York as his company CellCentric won the 36th annual Business Weekly Awards' coveted Business of the Year crown at Queens' College. ...
What does it take to build a world-class company in the UK?
The UK has no shortage of great ideas. The harder question is whether we have the capital, people and appetite for risk to turn more of them into world-class companies that grow and stay here. ...
Big Picture Bio founded to identify, design and optimise promising cancer combination therapies
New company founded by Deep Science Ventures veterans closes £1.5M (~$2M USD) pre-seed round and secures £700K (~$950K USD) Innovate UK fundingFounding team and advisors bring expertise from Deep Science Ventures, AstraZeneca, Exscientia and PhoreMostInitially focused on cancer and...
Acquisition of Corazon Health by HCML
Corazon Health announced today that it has been acquired by HCML, a leading provider of health, rehabilitation, case management, and treatment services. This acquisition enhances Corazon’s operational capacity, scaling its ability to support an expanded corporate client base across the ...
Your visitor has landed. Now what? Planning international arrivals to Cambridge
Somewhere over the Atlantic right now, a visiting researcher is trying to work out how to get from Heathrow to Cambridge. They have a hotel name, a meeting at nine tomorrow morning, and a phone that may not connect as expected when they land. ...
electronRx to launch purpleDx Pulmonary Disease Smartphone App for remote lung function monitoring
Cambridge, UK, 12 December 2024: electronRx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will launch purpleDx, a cardiopulmonary assessment app built to medical device standards, at ...
Research Roundup: Summer 2026
Welcome to our new research roundup. Each quarter we will highlight new research publications that include the NIHR BioResource and our participants. We have summarised each publication below, including links to the journal and any associated news articles. ...
Fuse Diagnostics raises £1 million to scale rapid point-of-need molecular testing platform
Financing will accelerate commercialisation of Fuse Diagnostics’ proprietary Flip platform, expanding its portfolio of rapid, laboratory-quality molecular diagnostics for high-value industrial and life science applicationsInvestment led by The FSE Group alongside existing and new angel ...
Blood markers linked to specific types of stroke identified by Cambridge researchers
Researchers at the University of Cambridge have identified two key chemical markers in the blood that are directly linked to different types of stroke caused by small vessel disease in the brain. The discovery could pave the way for earlier diagnosis, better disease tracking, and more t...
Charity seeks half-marathon runners for March 27
Charity seeks people who like a challenge to join their Cambridge Half Marathon Team on 14th March 2027 ...